Bills

26-5542 — Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Vaccines US Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services for the period of October 1, 2026 - September 30, 2027 using grant funds provided by the U.S. Department of Health and Human Services R

26-5542 is a measure before a local body in Texas. This page is what Rallybase holds about it and the date each part of it was read.

Its source has published no summary of it that Rallybase holds, and Rallybase prints none it cannot attribute to a source and a date.

As of 2026-09-20, the source's own latest action on it read: "Passed".

Identifier: 26-5542
Level: Local
State: Texas
Jurisdiction identifier: harriscountytx
Where that identifier comes from: harriscountytx — the Legistar jurisdiction that assigned this number. A city council has no session, so the URL carries the jurisdiction in that place instead.
Latest action, as the source published it: Passed
Read on: 2026-09-20

What you can do from here

Who sponsored it. The sync that loads these rows does not carry a sponsor.
How anybody voted on it. Rallybase has not read roll calls for this body, which is our coverage that is empty and not a statement about whether a vote was held.
When it is next scheduled to be taken up.